MX2018014680A - Agresividad de control a intervalo. - Google Patents

Agresividad de control a intervalo.

Info

Publication number
MX2018014680A
MX2018014680A MX2018014680A MX2018014680A MX2018014680A MX 2018014680 A MX2018014680 A MX 2018014680A MX 2018014680 A MX2018014680 A MX 2018014680A MX 2018014680 A MX2018014680 A MX 2018014680A MX 2018014680 A MX2018014680 A MX 2018014680A
Authority
MX
Mexico
Prior art keywords
computing device
person
glucose
current risk
risk metric
Prior art date
Application number
MX2018014680A
Other languages
English (en)
Inventor
L Duke David
Greenburg Alan
Ringemann Christian
Uday MANOHAR Chinmay
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2018014680A publication Critical patent/MX2018014680A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/82—Internal energy supply devices
    • A61M2205/8206—Internal energy supply devices battery-operated
    • A61M2205/8212—Internal energy supply devices battery-operated with means or measures taken for minimising energy consumption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Physics & Mathematics (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Diabetes (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Optics & Photonics (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se proporcionan un método y sistema para determinar un ajuste de la tasa basal de insulina en un sistema de monitoreo continuo de glucosa de una persona con diabetes. El método incluye recibir, por al menos un dispositivo de cómputo, una señal representativa de al menos una medición de glucosa; detectar, por el al menos un dispositivo de cómputo, un estado de glucosa de la persona con base en la señal, el estado de glucosa detectado incluyendo un nivel de glucosa de la persona y una tasa de cambio del nivel de glucosa; determinar, por el al menos un dispositivo de cómputo, una métrica de riesgo actual, la métrica de riesgo actual indicando un riesgo de al menos una de una condición hipoglucémica y una condición hiperglucémica de la persona; y calcular, por el al menos un dispositivo de cómputo, un ajuste a una tasa basal de un dispositivo de administración de terapia con base en la métrica de riesgo actual y un algoritmo de control a intervalo que comprende al menos un parámetro de agresividad.
MX2018014680A 2016-06-01 2017-05-09 Agresividad de control a intervalo. MX2018014680A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/170,450 US10332633B2 (en) 2016-06-01 2016-06-01 Control-to-range aggressiveness
PCT/US2017/031661 WO2017209902A1 (en) 2016-06-01 2017-05-09 Control-to-range aggressiveness

Publications (1)

Publication Number Publication Date
MX2018014680A true MX2018014680A (es) 2019-04-29

Family

ID=58745386

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018014680A MX2018014680A (es) 2016-06-01 2017-05-09 Agresividad de control a intervalo.

Country Status (14)

Country Link
US (1) US10332633B2 (es)
EP (1) EP3465491B8 (es)
KR (1) KR102428180B1 (es)
CN (1) CN109564774B (es)
AU (1) AU2017275392B2 (es)
CA (1) CA3025906A1 (es)
CY (1) CY1124983T1 (es)
DK (1) DK3465491T3 (es)
ES (1) ES2906640T3 (es)
HU (1) HUE057491T2 (es)
MX (1) MX2018014680A (es)
PL (1) PL3465491T3 (es)
PT (1) PT3465491T (es)
WO (1) WO2017209902A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9465917B2 (en) * 2014-05-30 2016-10-11 Roche Diabetes Care, Inc. Hazard based assessment patterns
JP6853198B2 (ja) * 2015-06-28 2021-03-31 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ １型糖尿病に適用するための人工膵臓の速度重み付けモデル予測制御
US10297350B2 (en) * 2016-06-01 2019-05-21 Roche Diabetes Care, Inc. Risk-based control-to-range
MA46606A (fr) * 2016-10-31 2019-09-04 Novo Nordisk As Systèmes et procédés d'estimation du risque d'un futur événement hypoglycémique
US11497851B2 (en) * 2017-03-31 2022-11-15 Lifescan Ip Holdings, Llc Maintaining maximum dosing limits for closed loop insulin management systems
EP3970611B1 (en) 2017-05-05 2023-12-06 Ypsomed AG Closed loop control of physiological glucose
EP3438858A1 (en) 2017-08-02 2019-02-06 Diabeloop Closed-loop blood glucose control systems and methods
CA3085930A1 (en) 2017-12-21 2019-06-27 Eli Lilly And Company Closed loop control of physiological glucose
CN108882480B (zh) * 2018-06-20 2020-06-05 新华网股份有限公司 舞台灯光和装置调节方法和系统
US20210100952A1 (en) * 2019-10-04 2021-04-08 Sean Brown Systems and Methods for Treating Hypoglycemia
US20210113766A1 (en) * 2019-10-21 2021-04-22 Tandem Diabetes Care, Inc. Systems and methods for automated insulin delivery response to inaccurate or missed glucose values
CN112402733B (zh) * 2020-02-26 2022-07-15 苏州喜全软件科技有限公司 基于电流脉冲渗透的胰岛素泵
EP4138656A1 (en) * 2020-04-23 2023-03-01 Medtronic MiniMed, Inc. Analyte sensor quality measures and related therapy actions for an automated therapy delivery system
US11583631B2 (en) 2020-04-23 2023-02-21 Medtronic Minimed, Inc. Intuitive user interface features and related functionality for a therapy delivery system
US11690955B2 (en) 2020-04-23 2023-07-04 Medtronic Minimed, Inc. Continuous analyte sensor quality measures and related therapy actions for an automated therapy delivery system
EP3984443A1 (en) 2020-10-13 2022-04-20 Diabeloop Computerized system for repeatedly determining a value of a control parameter of a fluid infusion system

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7395158B2 (en) 2000-05-30 2008-07-01 Sensys Medical, Inc. Method of screening for disorders of glucose metabolism
WO2002015777A1 (en) 2000-08-18 2002-02-28 Cygnus, Inc. Methods and devices for prediction of hypoglycemic events
US6575905B2 (en) 2000-09-22 2003-06-10 Knobbe, Lim & Buckingham Method and apparatus for real-time estimation of physiological parameters
US9247901B2 (en) 2003-08-22 2016-02-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US7278983B2 (en) 2002-07-24 2007-10-09 Medtronic Minimed, Inc. Physiological monitoring device for controlling a medication infusion device
US7291107B2 (en) 2004-08-26 2007-11-06 Roche Diagnostics Operations, Inc. Insulin bolus recommendation system
US8684922B2 (en) 2006-05-12 2014-04-01 Bao Tran Health monitoring system
US20080269714A1 (en) 2007-04-25 2008-10-30 Medtronic Minimed, Inc. Closed loop/semi-closed loop therapy modification system
GB0719969D0 (en) 2007-10-12 2007-11-21 Cambridge Entpr Ltd Substance monitoring and control in human or animal bodies
US7731659B2 (en) 2007-10-18 2010-06-08 Lifescan Scotland Limited Method for predicting a user's future glycemic state
WO2009075925A1 (en) 2007-12-13 2009-06-18 Shaya Steven A Method and apparatus to calculate diabetic sensitivity factors affecting blood glucose
US8734422B2 (en) 2008-08-31 2014-05-27 Abbott Diabetes Care Inc. Closed loop control with improved alarm functions
GB2466183A (en) 2008-12-09 2010-06-16 Cambridge Entpr Ltd Closed loop diabetes management system
WO2010099313A1 (en) * 2009-02-25 2010-09-02 University Of Virginia Patent Foundation Cgm-based prevention of hypoglycemia via hypoglycemia risk assessment and smooth reduction insulin delivery
EP2433235A2 (en) 2009-05-22 2012-03-28 Abbott Diabetes Care, Inc. Safety features for integrated insulin delivery system
EP3173014B1 (en) * 2009-07-23 2021-08-18 Abbott Diabetes Care, Inc. Real time management of data relating to physiological control of glucose levels
US20110071464A1 (en) 2009-09-23 2011-03-24 Medtronic Minimed, Inc. Semi-closed loop insulin delivery
US8843321B2 (en) 2010-01-26 2014-09-23 Roche Diagnostics Operations, Inc. Methods and systems for processing glucose data measured from a person having diabetes
US8579879B2 (en) 2010-02-19 2013-11-12 Medtronic Minimed, Inc. Closed-loop glucose control startup
US8532933B2 (en) 2010-06-18 2013-09-10 Roche Diagnostics Operations, Inc. Insulin optimization systems and testing methods with adjusted exit criterion accounting for system noise associated with biomarkers
US8774889B2 (en) 2010-12-22 2014-07-08 Roche Diagnostics Operations, Inc. Patient monitoring system with efficient pattern matching algorithm
US8589106B2 (en) 2010-12-22 2013-11-19 Roche Diagnostics Operations, Inc. Calibration of a handheld diabetes managing device that receives data from a continuous glucose monitor
US20140088392A1 (en) 2011-02-11 2014-03-27 Abbott Diabetes Care Inc. Feedback from Cloud or HCP to Payer or Patient via Meter or Cell Phone
EP2748747B1 (en) 2011-08-26 2020-08-26 University Of Virginia Patent Foundation Method, system and computer readable medium for adaptive advisory control of diabetes
US20130338630A1 (en) * 2012-06-07 2013-12-19 Medtronic Minimed, Inc. Diabetes therapy management system for recommending adjustments to an insulin infusion device
US10881339B2 (en) 2012-06-29 2021-01-05 Dexcom, Inc. Use of sensor redundancy to detect sensor failures
US9623179B2 (en) 2012-08-30 2017-04-18 Medtronic Minimed, Inc. Safeguarding techniques for a closed-loop insulin infusion system
US9364609B2 (en) 2012-08-30 2016-06-14 Medtronic Minimed, Inc. Insulin on board compensation for a closed-loop insulin infusion system
US9504412B2 (en) 2012-09-17 2016-11-29 Lifescan, Inc. Method and system to derive glycemic patterns from clustering of glucose data
US9592002B2 (en) 2012-09-21 2017-03-14 Lifescan, Inc. Method and system to derive multiple glycemic patterns from glucose measurements during time of the day
US10463282B2 (en) 2012-10-04 2019-11-05 Roche Diabetes Care, Inc. System and method for assessing risk associated with a glucose state
US9119529B2 (en) 2012-10-30 2015-09-01 Dexcom, Inc. Systems and methods for dynamically and intelligently monitoring a host's glycemic condition after an alert is triggered
US10383580B2 (en) 2012-12-31 2019-08-20 Abbott Diabetes Care Inc. Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
US9351670B2 (en) 2012-12-31 2016-05-31 Abbott Diabetes Care Inc. Glycemic risk determination based on variability of glucose levels
US9227014B2 (en) 2013-02-07 2016-01-05 The Board Of Trustees Of The Laland Stanford Junior University Kalman filter based on-off switch for insulin pump
CN105899127B (zh) 2013-11-14 2019-09-24 加州大学董事会 血糖率上升检测器：用于健康监测系统的膳食检测模块
US10722650B2 (en) * 2014-03-28 2020-07-28 Roche Diabetes Care, Inc. System and method for adjusting therapy based on risk associated with a glucose state
US9465917B2 (en) 2014-05-30 2016-10-11 Roche Diabetes Care, Inc. Hazard based assessment patterns

Also Published As

Publication number Publication date
KR102428180B1 (ko) 2022-08-01
HUE057491T2 (hu) 2022-05-28
EP3465491B8 (en) 2022-03-02
BR112018074903A2 (pt) 2019-03-06
PT3465491T (pt) 2022-02-10
DK3465491T3 (da) 2022-02-21
CN109564774A (zh) 2019-04-02
US20170348483A1 (en) 2017-12-07
WO2017209902A1 (en) 2017-12-07
EP3465491A1 (en) 2019-04-10
AU2017275392A1 (en) 2019-01-03
US10332633B2 (en) 2019-06-25
AU2017275392B2 (en) 2022-03-03
PL3465491T3 (pl) 2022-03-28
EP3465491B1 (en) 2021-12-15
CA3025906A1 (en) 2017-12-07
BR112018074903A8 (pt) 2023-01-31
CY1124983T1 (el) 2023-01-05
KR20190013921A (ko) 2019-02-11
ES2906640T3 (es) 2022-04-19
CN109564774B (zh) 2024-05-24

Similar Documents

Publication Publication Date Title
MX2018014680A (es) Agresividad de control a intervalo.
MX2018014683A (es) Protecciones contra fallas de control a intervalo.
US20220262475A1 (en) Adaptive signal processing
RU2017113941A (ru) Поддержка принятия решения для пациентов с диабетом
RU2017138101A (ru) Способы и системы для анализа данных о содержании глюкозы, измеренных у больного диабетом
RU2017130943A (ru) Способы, системы и носимое устройство для получения множества показателей состояния здоровья
WO2014167418A3 (en) Measurement of cerebral physiologic parameters using bioimpedance
MX2013011679A (es) Dispositivo y metodo para detectar enfermedades oftalmicas y/o cerebrales.
WO2018162728A3 (en) Device, apparatus and method of determining skin perfusion pressure
SG10201804607RA (en) System and method for facilitating delivery of patient-care
WO2012058337A3 (en) Continuous analyte monitor data recording device operable in a blinded mode
RU2015126534A (ru) Система и способ для оптимизирования частоты сбора данных и пороговых значений для алгоритма обнаружения ухудшения состояния
CA2883595C (en) System and method for assessing risk associated with a glucose state
WO2010147659A3 (en) Closed-loop glucose and/or insulin control system
EP3422926B1 (en) Probability based controller gain
RU2015129489A (ru) Метод и система гибридного контроллера с прогнозируемой моделью контроля целевого значения и контроля диапазона для искусственной поджелудочной железы
WO2015148930A1 (en) System and method for adjusting therapy based on risk associated with a glucose state
GB2526503A (en) Circulation monitoring system
RU2013157909A (ru) Устройство для обнаружения лихорадки
ATE556651T1 (de) Überwachung von vitalparametern eines patienten mit einem körpersensornetz
WO2014035570A3 (en) Safeguarding measures for a closed-loop insulin infusion system
EP4233987A3 (en) Blood treatment systems
RU2015113449A (ru) Способ и система для указания на гликемические воздействия команд инсулиновой инфузионной помпы
MX2016012133A (es) Determinacion de un indicador de riesgo de salud.
JP2013509278A (ja) 融合データ低血糖警告を閉ループ血糖管理システムに組み込むためのシステム及び方法